The study of nanoparticles has grown in significance during the last several years. Nanoparticles are a kind of material that is composed of very tiny particles. Nanoparticle characteristics vary greatly depending on their size and form. The surface of a nanoparticle significantly affects its optical, mechanical, magnetic, and other characteristics. Nanoparticles are categorised according to their size, origin and chemical composition. We created nanoparticles using both top-down and bottom-up techniques. In this article, we discuss various different methods for creating nanomaterials, such as sol-gel processes, gas condensation, vacuum deposition and vaporisation, chemical vapour deposition and condensate, mechanical attrition, chemical precipitation, electrodeposition, and chemical vapour condensation. When it comes to creating nanoparticles, green synthesis is one of the most effective approaches. In this article, we explore eco-friendly techniques for manufacturing alloy nanoparticles, silver, gold, silver oxide and silver sulphide. We also explore the process by which microorganisms in this setting produce nanoparticles. Size and form must be maintained under certain conditions. We consider ways in which to enhance the production of nanoparticles in the future. The risks posed by nanoparticles and the ways in which to mitigate them were also taken into account.

Background/Objectives: Metallic NPs have been explored for various therapeutic uses owing to utilitarian physicochemical characteristics such as antibacterial, anti-inflammatory, and healing properties. The objective of this study is to evaluate the therapeutic potential of novel silver carbonate nanostructures in promoting wound healing and their antibacterial activity against Pseudomonas chengduensis and Staphylococcus aureus. Methods: In this work, we prepared Ag₂CO₃ nanoparticles through a two-step methodology that was expected to improve the material’s biomedical performance and biocompatibility. The characterization and assessment of synthesized NPs biocompatibility were conducted using hemolysis assays on the blood of a healthy male human. Further, we performed molecular docking analysis to confirm interactions of silver NPs with biological molecules. Results: In detail, the synthesized NPs showed <5% hemolysis activity at various concentrations, confirming their therapeutic applicability. Additionally, the NPs had good metabolic activities; they raised the T3/T4 hormone content and acted effectively on Insulin-like Growth Factor 1 (IGF-1) in diabetic models. They also facilitated the rate of repair by having the diabetic wounds reach 100% re-epithelialization by day 13, unlike the control group, which reached the same level only by day 16. The synthesized Ag₂CO₃ NPs exhibited high antimicrobial potential against both Pseudomonas chengduensis and Staphylococcus aureus, hence being a potential material that can be used for infection control in biomedical tissue engineering applications. Conclusions: These findings concluded that novel synthesis methods lead to the formation of NPs with higher therapeutic prospects; however, studies of their metaphysical and endocrinological effects are necessary.

Nanoparticles (NPs) are at the forefront as they are providing unprecedented solutions to obstacles and issues in treating neurodegenerative diseases. Due to their size, surface characteristics, and ability to be functionalized, these carriers can directly deliver therapeutics across what is considered one of the main barriers to central nervous system (CNS) treatment, the blood-brain barrier (BBB). Through nano-technology, anti-disease agents such as Alzheimer’s, Parkinson’s, and Huntington’s therapies become more bioavailable, specific in action, and with fewer side effects. The NPs serve as molecular carriers that facilitate transport across the BBB by receptor-mediated transcytosis or by disruption of the barrier with a view to properly delivering drugs to the neural tissues. Some of the therapeutic applications of nanotechnology also present the concept of molecular medicine since the NPs are designed to deliver drugs in accordance with specific biomolecule signals. Besides the therapeutic applications, NPs replace the traditional contrast media for magnetic resonance imaging (MRI) and positron emission tomography (PET) scans for better diagnosis as well as disease tracking in the early stages. In addition, their effects on solubility increase the therapeutic potential of earlier useless compounds, and the preservation of bioactive molecules from degradation increases the therapeutic capacity of medications. Neurodegenerative disorders are marked by oxidative stress and inflammation that contribute to the disease severity; thus, liposomes, dendrimers, and polymeric NPs encapsulate antioxidants and anti-inflammatory compounds, so they target the areas most affected by the disease. Such sophisticated systems minimize the extension of neuronal deterioration and enhance the lot of such patients. The “theranostic” NPs allow for continuous diagnosis and treatment by containing both diagnostic and therapeutic features. These have created unprecedented opportunities to meet the unmet needs in CNS disorders and may revolutionize the evolution of managing neurodegenerative diseases and innovative neuroimaging procedures in the future.

Silver iodide (AgI) nanostructures have been considered as promising candidates for optical biosensors owing to their optical characteristics of optical properties, including tunable surface plasmon resonance (SPR) and fluorescence enhancement. Such properties let one analyze biomolecules with high sensitivity, which makes them ultra-useful in diagnostics. The formed AgI nanostructures can be synthesized using chemical precipitation and template methods that enable fine-tuning of the morphology and crystallinity of the final nanostructure. The presence of SPR enhances optical signals potentially, and fluorescence enhancement helps visualize biomolecule interactions easier as the analyte concentration is usually low. Such uses of biosensors include applications in proteins, nucleic acids, and other biomolecules for progress in disease diagnosis and pharmacogenomics. Moreover, the good biocompatibility level of the created AgI nanostructures makes it possible to integrate them into biological systems safely, increasing their usage in medicine. This integration of their appealing optics, biosensing operating principles, and biocompatibility establishes their centrality in the creation of future photonic biosensors for faster, intuitive, and painless detection.